GENE ONLINE|News &
Opinion
Blog

2025-03-26|

GSK Launches First-of-Its-Kind Study on Shingles Vaccine and Dementia Risk in the UK

by Denisse Sandoval
Share To
GlaxoSmithKline plc (GSK) announced a research collaboration with the UK Dementia Research Institute (UK DRI) and Health Data Research UK (HDR UK) to study neurodegeneration …

GSK Launches First-of-Its-Kind Study on Shingles Vaccine and Dementia Risk in the UK Read More »

GO Prime with only $1.49 now

LATEST
EirGenix Leverages Dual Engines of CDMO and Biosimilars to Capitalize on Global Biopharma Supply Chain Realignment
2026-06-11
nVent Electric Appoints New Chief Strategy and Revenue Officers
2026-06-10
Snail Games Announces Bellwright Console Launch and New ARK Content at IGN Live 2026
2026-06-10
BJJLink Launches AI-Powered Platform for Martial Arts Gym Member Acquisition
2026-06-10
Trump Media and TAE Technologies Provide Merger Status Update on June 10, 2026
2026-06-10
OZOP Energy Solutions Partners with Tenace Consulting for Southern California Distribution
2026-06-10
Agassi Sports Entertainment Signs Darren Cahill to Lead Global Coaching and Technology Initiatives
2026-06-10
Scroll to Top